A judge has granted preliminary approval for the University of North Carolina (UNC) to settle a lawsuit over allegations that a no-hire agreement between the university and Duke University violated antitrust laws.
The lawsuit was filed in 2015 on behalf of Danielle Seaman, who was an assistant professor of radiology at Duke, who says she was passed over for a similar job at UNC because of an agreement between medical schools at the two institutions not to hire each other’s employees for positions of the same rank.
The law firm representing Seaman announced the partial settlement news this morning. Duke has not settled in the case. Duke has denied the allegations and The Herald-Sun reports that Nancy Andrews, the former dean of Duke’s medical school, and other faculty have filed statements in the same vein.
In the lawsuit, Seaman says she had been trying to get a job at Carolina for three years and was told in 2015 that she was a strong candidate but couldn’t be hired because “lateral moves of faculty between Duke and UNC are not permitted.”
In an email included in the lawsuit, UNC’s chief of cardiothoracic imaging says this arrangement had been in place for a few years and suggested it was intended to suppress salaries.
“The ‘guideline’ was generated in response to an attempted recruitment by Duke a couple of years ago of the entire UNC bone marrow transplant team; UNC had to generate a large retention package to keep the team intact,” the email reads.
“Because Duke/DUHS and UNC/UNC Health are the two largest academic medical systems in the state, their no-hire agreement has reduced competition for medical facility faculty and certain staff, thereby suppressing faculty and staff pay,” the lawsuit says.
Full Content: Herald Sun & Business Wire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Files Suit Against Liquor Giant Southern Glazer’s Over Discount Disparities
Dec 12, 2024 by
CPI
Racing Rivals Accuse NASCAR of Retaliation in High-Stakes Antitrust Battle
Dec 12, 2024 by
CPI
Samsung Challenges Indian Antitrust Investigation, Calls Raid “Unlawful”
Dec 12, 2024 by
CPI
European Sites Criticize Google’s Compliance Efforts with DMA
Dec 12, 2024 by
CPI
Banco BPM Overcomes Regulatory Hurdle in $1.7 Billion Bid
Dec 12, 2024 by
CPI
Antitrust Mix by CPI
Coopetition in The Pharma Industry: Challenges for Antitrust
Dec 12, 2024 by
Juan Delgado & Lourdes Sosa
Symmetry and the Sixth Force: The Essential Role of Complements
Dec 12, 2024 by
Adam Brandenburger & Barry Nalebuff
ESG Collaborations in Light of European Antitrust Policy and Enforcement Trends
Dec 12, 2024 by
Christian Ritz, Julia Gingelmaier & Kyra Harmes
Antitrust Chronicle® – Co-opetition
Dec 11, 2024 by
CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI